Fatal glioblastoma multiforme in a patient with neurofibromatosis type I: the dilemma of systematic medical follow-up

[1]  D. Baralle,et al.  Malignancy in neurofibromatosis type 1 [Abstract] , 2005 .

[2]  D. Gutmann,et al.  Neurofibromin Regulates Neural Stem Cell Proliferation, Survival, and Astroglial Differentiation In Vitro and In Vivo , 2005, The Journal of Neuroscience.

[3]  L. Kluwe,et al.  Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene. , 2005, Anticancer research.

[4]  D. Gutmann,et al.  Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes. , 2005, Cancer research.

[5]  S. Plon,et al.  Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1 , 2004, American journal of medical genetics. Part A.

[6]  C. James,et al.  Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1 , 2003, Neurology.

[7]  J. Wellons,et al.  Pediatric High‐Grade Gliomas , 2003, Cancer journal.

[8]  D. Gutmann,et al.  Astrocyte-Specific Inactivation of the Neurofibromatosis 1 Gene (NF1) Is Insufficient for Astrocytoma Formation , 2002, Molecular and Cellular Biology.

[9]  B. Katz.  Neurofibromatosis: Phenotype, Natural History and Pathogenesis , 2001 .

[10]  B. Korf.  Malignancy in neurofibromatosis type 1. , 2000, The oncologist.

[11]  Karlyne M. Reilly,et al.  Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects , 2000, Nature Genetics.

[12]  S. Huson,et al.  Unusual clustering of brain tumours in a family with NF1 and variable expression of cutaneous features , 1999, Journal of medical genetics.

[13]  P. Griffiths,et al.  Neurofibromatosis Bright Objects in Children With Neurofibromatosis Type 1: A Proliferative Potential? , 1999, Pediatrics.

[14]  J. Charrow,et al.  Intracranial gliomas in neurofibromatosis type 1. , 1999, American journal of medical genetics.

[15]  J. Charrow,et al.  Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. , 1994, The Journal of pediatrics.

[16]  P. Balestri,et al.  Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1 , 1993, Child's Nervous System.

[17]  D. Easton,et al.  An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. , 1993, American journal of human genetics.

[18]  V. Riccardi,et al.  Neurofibromatosis: Phenotype, Natural History and Pathogenesis , 1993 .

[19]  L. Martí-Bonmatí,et al.  Imaging considerations of central nervous system manifestations in pediatric patients with neurofibromatosis type 1 , 2005, Pediatric Radiology.

[20]  P. Cornu,et al.  High-intensity lesion on T1-weighted MR images in neurofibromatosis type 1: a case of premalignant lesion , 2005, Acta Neurochirurgica.

[21]  Health supervision for children with neurofibromatosis. American Academy of Pediatrics Committee on Genetics. , 1995, Pediatrics.